Cargando…

The Concentration of Fibronectin and MMP-1 in Patients with Alzheimer’s Disease in Relation to the Selected Antioxidant Elements and Eating Habits

Alzheimer’s disease (AD) is a neurodegenerative disease and the most common form of dementia in the elderly. In recent years, markers of this disease have been researched, with an emphasis on prophylaxis. The aim of this study is to evaluate the concentration of fibronectin and MMP-1 in serums in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogdan, Sylwia, Puścion-Jakubik, Anna, Klimiuk, Katarzyna, Socha, Katarzyna, Kochanowicz, Jan, Gorodkiewicz, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657660/
https://www.ncbi.nlm.nih.gov/pubmed/36362588
http://dx.doi.org/10.3390/jcm11216360
_version_ 1784829753114492928
author Bogdan, Sylwia
Puścion-Jakubik, Anna
Klimiuk, Katarzyna
Socha, Katarzyna
Kochanowicz, Jan
Gorodkiewicz, Ewa
author_facet Bogdan, Sylwia
Puścion-Jakubik, Anna
Klimiuk, Katarzyna
Socha, Katarzyna
Kochanowicz, Jan
Gorodkiewicz, Ewa
author_sort Bogdan, Sylwia
collection PubMed
description Alzheimer’s disease (AD) is a neurodegenerative disease and the most common form of dementia in the elderly. In recent years, markers of this disease have been researched, with an emphasis on prophylaxis. The aim of this study is to evaluate the concentration of fibronectin and MMP-1 in serums in relation to levels of antioxidant elements, as well as eating habits in the group of patients with AD (n = 110). The control group consisted of 60 healthy people. The conducted studies showed that patients with AD are characterized by a significantly higher median concentration of fibronectin compared to healthy subjects (652.06 vs. 268.31 µg/mL), but a significantly lower median of MMP-1 (4.62 vs. 18.09 ng/mL). Significant inverse correlations between MMP-1 and the concentration of antioxidant elements, as well as positive correlations between MMP-1 vs. Total Antioxidant Status (TAS) and MMSE, were observed. Multiple regressions showed that the concentration of fibronectin can be explained in 28% cases by eating habits, and by MMP-1 in 25%. Nutritional modifications to reduce the consumption of fruit, meat and processed products can be part of AD prevention.
format Online
Article
Text
id pubmed-9657660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96576602022-11-15 The Concentration of Fibronectin and MMP-1 in Patients with Alzheimer’s Disease in Relation to the Selected Antioxidant Elements and Eating Habits Bogdan, Sylwia Puścion-Jakubik, Anna Klimiuk, Katarzyna Socha, Katarzyna Kochanowicz, Jan Gorodkiewicz, Ewa J Clin Med Article Alzheimer’s disease (AD) is a neurodegenerative disease and the most common form of dementia in the elderly. In recent years, markers of this disease have been researched, with an emphasis on prophylaxis. The aim of this study is to evaluate the concentration of fibronectin and MMP-1 in serums in relation to levels of antioxidant elements, as well as eating habits in the group of patients with AD (n = 110). The control group consisted of 60 healthy people. The conducted studies showed that patients with AD are characterized by a significantly higher median concentration of fibronectin compared to healthy subjects (652.06 vs. 268.31 µg/mL), but a significantly lower median of MMP-1 (4.62 vs. 18.09 ng/mL). Significant inverse correlations between MMP-1 and the concentration of antioxidant elements, as well as positive correlations between MMP-1 vs. Total Antioxidant Status (TAS) and MMSE, were observed. Multiple regressions showed that the concentration of fibronectin can be explained in 28% cases by eating habits, and by MMP-1 in 25%. Nutritional modifications to reduce the consumption of fruit, meat and processed products can be part of AD prevention. MDPI 2022-10-27 /pmc/articles/PMC9657660/ /pubmed/36362588 http://dx.doi.org/10.3390/jcm11216360 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bogdan, Sylwia
Puścion-Jakubik, Anna
Klimiuk, Katarzyna
Socha, Katarzyna
Kochanowicz, Jan
Gorodkiewicz, Ewa
The Concentration of Fibronectin and MMP-1 in Patients with Alzheimer’s Disease in Relation to the Selected Antioxidant Elements and Eating Habits
title The Concentration of Fibronectin and MMP-1 in Patients with Alzheimer’s Disease in Relation to the Selected Antioxidant Elements and Eating Habits
title_full The Concentration of Fibronectin and MMP-1 in Patients with Alzheimer’s Disease in Relation to the Selected Antioxidant Elements and Eating Habits
title_fullStr The Concentration of Fibronectin and MMP-1 in Patients with Alzheimer’s Disease in Relation to the Selected Antioxidant Elements and Eating Habits
title_full_unstemmed The Concentration of Fibronectin and MMP-1 in Patients with Alzheimer’s Disease in Relation to the Selected Antioxidant Elements and Eating Habits
title_short The Concentration of Fibronectin and MMP-1 in Patients with Alzheimer’s Disease in Relation to the Selected Antioxidant Elements and Eating Habits
title_sort concentration of fibronectin and mmp-1 in patients with alzheimer’s disease in relation to the selected antioxidant elements and eating habits
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657660/
https://www.ncbi.nlm.nih.gov/pubmed/36362588
http://dx.doi.org/10.3390/jcm11216360
work_keys_str_mv AT bogdansylwia theconcentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT puscionjakubikanna theconcentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT klimiukkatarzyna theconcentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT sochakatarzyna theconcentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT kochanowiczjan theconcentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT gorodkiewiczewa theconcentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT bogdansylwia concentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT puscionjakubikanna concentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT klimiukkatarzyna concentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT sochakatarzyna concentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT kochanowiczjan concentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits
AT gorodkiewiczewa concentrationoffibronectinandmmp1inpatientswithalzheimersdiseaseinrelationtotheselectedantioxidantelementsandeatinghabits